Loading stock data…
$19.77+0.09 (+0.46%)
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally.
SI-BONE, Inc. in the Healthcare sector is trading at $19.77 with a market capitalization of $829M. Wall Street consensus targets $25.22 (9 analysts), implying a +27.6% move over the next 12 months. The stock is currently 10% below its 52-week high of $21.89, remaining 21.1% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $56.01M↑ | $52.59M↓ | $56.35M↑ | $48.66M | $48.63M |
| Gross Profit | $44.55M↑ | $41.94M↓ | $44.53M↑ | $38.85M↑ | $38.81M |
| Operating Income | -$4.81M↑ | -$5.09M↓ | -$2.46M↑ | -$5.38M↑ | -$7.00M |
| Net Income | -$4.09M↑ | -$4.33M↓ | -$1.64M↑ | -$4.57M↑ | -$6.15M |
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented tita...